Literature DB >> 31375569

Quantitative Clinical Nuclear Cardiology, Part 1: Established Applications.

Ernest V Garcia1, Piotr Slomka2, Jonathan B Moody3, Guido Germano2, Edward P Ficaro3,4.   

Abstract

SPECT myocardial perfusion imaging has attained widespread clinical acceptance as a standard of care for patients with known or suspected coronary artery disease. A significant contribution to this success has been the use of computer techniques to provide objective quantitative assessment in the standardization of the interpretation of these studies. Software platforms have been developed as a pipeline to provide the quantitative algorithms researched, developed and validated to be clinically useful so diagnosticians everywhere can benefit from these tools. The goal of this continuing medical education article (part 1) is to describe the many quantitative tools that are clinically established and, more importantly, how clinicians should use them routinely in interpretation, clinical management, and therapy guidance for patients with coronary artery disease.
© 2019 Society of Nuclear Medicine and Molecular Imaging & American Society of Nuclear Cardiology.

Entities:  

Keywords:  ischemic burden; myocardial perfusion imaging; quantitative LV function; quantitative LV perfusion; summed stress score; transient ischemic dilation

Mesh:

Year:  2019        PMID: 31375569      PMCID: PMC6836865          DOI: 10.2967/jnumed.119.229799

Source DB:  PubMed          Journal:  J Nucl Med        ISSN: 0161-5505            Impact factor:   10.057


  78 in total

1.  Left ventricular function and perfusion from gated SPECT perfusion images: an integrated method.

Authors:  T L Faber; C D Cooke; R D Folks; J P Vansant; K J Nichols; E G DePuey; R I Pettigrew; E V Garcia
Journal:  J Nucl Med       Date:  1999-04       Impact factor: 10.057

2.  Regional left-ventricular diastolic wall motion assessed by a new program for ECG-gated myocardial perfusion SPECT in early-stage heart failure.

Authors:  Akira Yamamoto; Naoto Takahashi; Kazuya Abe; Yuko Kobayashi; Jin Tamai; Kazuo Munakata
Journal:  J Nucl Cardiol       Date:  2008-04-16       Impact factor: 5.952

3.  Evaluation of left ventricular mass on cadmium-zinc-telluride imaging: Validation against cardiac magnetic resonance.

Authors:  Alessia Gimelli; Riccardo Liga; Serena Magro; Salvatore Novo; Roberto Pedrinelli; Anna Sonia Petronio; Paolo Marzullo; Alessia Pepe
Journal:  J Nucl Cardiol       Date:  2017-10-17       Impact factor: 5.952

Review 4.  Direct myocardial ischemia imaging: a new cardiovascular nuclear imaging paradigm.

Authors:  Diwakar Jain; Zuo-Xiang He; Vikram Lele; Wilbert S Aronow
Journal:  Clin Cardiol       Date:  2014-12-08       Impact factor: 2.882

Review 5.  Noninvasive assessment myocardial viability: current status and future directions.

Authors:  Kevin C Allman
Journal:  J Nucl Cardiol       Date:  2013-06-15       Impact factor: 5.952

6.  Quantitative Tc-99m sestamibi attenuation-corrected SPECT: development and multicenter trial validation of myocardial perfusion stress gender-independent normal database in an obese population.

Authors:  Gabriel B Grossman; Ernest V Garcia; Timothy M Bateman; Gary V Heller; Lynne L Johnson; Russell D Folks; S James Cullom; James R Galt; James A Case; Cesar A Santana; Raghuveer K Halkar
Journal:  J Nucl Cardiol       Date:  2004 May-Jun       Impact factor: 5.952

7.  Myocardial viability in patients with chronic coronary artery disease. Comparison of 99mTc-sestamibi with thallium reinjection and [18F]fluorodeoxyglucose.

Authors:  V Dilsizian; J A Arrighi; J G Diodati; A A Quyyumi; K Alavi; S L Bacharach; J A Marin-Neto; P T Katsiyiannis; R O Bonow
Journal:  Circulation       Date:  1994-02       Impact factor: 29.690

8.  Prognostic implications of combined prone and supine acquisitions in patients with equivocal or abnormal supine myocardial perfusion SPECT.

Authors:  Sean W Hayes; Andrea De Lorenzo; Rory Hachamovitch; Sanjay C Dhar; Patrick Hsu; Ishac Cohen; John D Friedman; Xingping Kang; Daniel S Berman
Journal:  J Nucl Med       Date:  2003-10       Impact factor: 10.057

9.  Quantification of left ventricular volumes and ejection fraction from gated 99mTc-MIBI SPECT: validation of an elastic surface model approach in comparison to cardiac magnetic resonance imaging, 4D-MSPECT and QGS.

Authors:  Lars Stegger; Claudia S A Lipke; Peter Kies; Bernd Nowak; Otmar Schober; Udalrich Buell; Michael Schäfers; Wolfgang M Schaefer
Journal:  Eur J Nucl Med Mol Imaging       Date:  2007-01-10       Impact factor: 10.057

10.  Novel solid-state-detector dedicated cardiac camera for fast myocardial perfusion imaging: multicenter comparison with standard dual detector cameras.

Authors:  Fabio P Esteves; Paolo Raggi; Russell D Folks; Zohar Keidar; J Wells Askew; Shmuel Rispler; Michael K O'Connor; Liudmilla Verdes; Ernest V Garcia
Journal:  J Nucl Cardiol       Date:  2009-08-18       Impact factor: 5.952

View more
  4 in total

1.  Adding value to myocardial perfusion scintigraphy: A prediction tool to predict adverse cardiac outcomes and risk stratify.

Authors:  Ricardo A Nieves; Syed Bukhari; Matthew E Harinstein
Journal:  J Nucl Cardiol       Date:  2021-06-24       Impact factor: 5.952

Review 2.  Quantitative clinical nuclear cardiology, part 2: Evolving/emerging applications.

Authors:  Piotr J Slomka; Jonathan B Moody; Robert J H Miller; Jennifer M Renaud; Edward P Ficaro; Ernest V Garcia
Journal:  J Nucl Cardiol       Date:  2020-10-16       Impact factor: 5.952

3.  Prediction of 2-year major adverse cardiac events from myocardial perfusion scintigraphy and clinical risk factors.

Authors:  William D Leslie; Mark Bryanton; Andrew Goertzen; Piotr Slomka
Journal:  J Nucl Cardiol       Date:  2021-04-28       Impact factor: 3.872

4.  Does quantification of [11C]meta-hydroxyephedrine and [13N]ammonia kinetics improve risk stratification in ischemic cardiomyopathy.

Authors:  Jean Z Wang; Jason G E Zelt; Nicole Kaps; Aaryn Lavallee; Jennifer M Renaud; Benjamin Rotstein; Rob S B Beanlands; James A Fallavollita; John M Canty; Robert A deKemp
Journal:  J Nucl Cardiol       Date:  2021-08-02       Impact factor: 5.952

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.